HealthSource vs REMEVi
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Compounded semaglutide or tirzepatide, by weekly injection or as a nightly tablet, in all 50 states from $199 every four weeks.
- semaglutide
- $199 per 4 weeks
- tirzepatide
- $299 per 4 weeks
Before enrolling
You pay before the medical intake — the questionnaire link appears only after checkout, and withdrawing once you have filled it in costs you $25–$45 for the provider review
Desk Score
Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language.
- semaglutide
- $219/mo
- tirzepatide
- $319/mo
Before enrolling
The flat rate is a higher entry price than teaser-led competitors
Our review of REMEVi gives it 86/100 (B), while our review of HealthSource gives it 84/100 (B). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
84/100
B
86/100
B
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | HealthSource | REMEVi |
|---|---|---|
| Semaglutide | $199 per 4 weeksFull plan terms$199 every 4 weeks month-to-month (13 charges a year, all doses, compounded) | $219/moFull plan terms$219/mo month-to-month; $189/mo on a 12-week plan; $179/mo on a 24-week plan; same price at every dose; oral tablet $349/mo month-to-month or $309/mo on a 12-week plan |
| Tirzepatide | $299 per 4 weeksFull plan terms$299 every 4 weeks month-to-month (13 charges a year, all doses, compounded) | $319/moFull plan terms$319/mo month-to-month; $249/mo on a 12-week plan; $229/mo on a 24-week plan; same price at every dose; compounded injectable |
| Coverage | All 50 states | All 50 states and DC |
| Brand-name | Not confirmed here | Not confirmed here |
| Oral option | Oral option listed | Oral option listed |
| Best for | Compounded semaglutide or tirzepatide, by weekly injection or as a nightly tablet, in all 50 states from $199 every four weeks. | Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language. |
| Desk Score | 84/100B | 86/100B |
The verdict
Desk pick — REMEViREMEVi has the higher Desk Score, but HealthSource may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Compounded semaglutide or tirzepatide, by weekly injection or as a nightly tablet, in all 50 states from $199 every four weeks.
Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs HealthSource
- CoreAge Rx vs REMEVi
- Curex vs HealthSource
- Curex vs REMEVi
- BetterMe Rx vs HealthSource
- BetterMe Rx vs REMEVi
Or see the full comparison hub and the complete ranking.